Term
|
Definition
Persistant painless lymphadenopathy majority asymptomatic Const Symp-- fever, night sweats, wt loss-- 25-30% Pel-Ebstein Fever Generalized Pruritis Pain in lymph post-alcohol herpes-zoster/mycofungal infections Splenomegaly-- more in kids |
|
|
Term
Hodgkin's Lymphoma distinctive cells |
|
Definition
Reed-sternberg cells- OWL EYES |
|
|
Term
|
Definition
Bimodal Age distribution M>W Whites>AA Younger in India-- EBV |
|
|
Term
|
Definition
CBC, ESR, Serum Chemistry, LDH Level, Immunophenotyping, Lymph node histopathology CXR, CT, PET, Gallium |
|
|
Term
Hodgkin's Diagnostic Interpretations |
|
Definition
Elevated ESR Elevated LDH Reed-sternberg cells most cells are normal lymphoid, plasma cells, monocytes, and eosinophils |
|
|
Term
|
Definition
Combo Chemo most patients -MOPP -ABVD -BEACOPP Relapse after radiation-- chemo Chemo + Radiation for bulky mass Chemo for earlier stages in testing... |
|
|
Term
|
Definition
Fever, anemia, infections marked lymphadenopathy-- recurring Const sympt-- fever, night sweats, wt loss (B sympt in high grade) hepatosplenomegaly |
|
|
Term
Non-Hodgkin's Diagnostic Interpretations |
|
Definition
No Reed-sternberg cells or eosinophils cytopenias Chromosomal translocations Waldeyer's ring-- GI PBS normal but some lymphomas in leukemic phase Serum LDH increased CXR-- mediastinal mass |
|
|
Term
Non-Hodgkin's distribution |
|
Definition
common, 4th ranked hematology cancer 1:46M:56W (3:1, M:W) Elderly 55-75 median age |
|
|
Term
Non-Hodgkin's Diagnostic test |
|
Definition
CBC, Chemistries, urinalysis, CT, Bone marrow biopsy/aspirate, lumbar puncture, PBS, Serum LDH, CXR |
|
|
Term
|
Definition
Chemo + Alkylating agents: Chlorambucil + CVP Fludarabine Rituximab-- salvage therapy Short course chemo + CHOP + localized radiation Chemo + CHOP for 6-8 cycles CHOP + Rituximab for elderly |
|
|
Term
allogenic transplantation |
|
Definition
used for some patients with aggressive low grade lymphomas |
|
|
Term
|
Definition
for patients with limited indolent disease (lymphoma) |
|
|
Term
Multiple Myeloma Treatment that's potentially curable |
|
Definition
potentially Curable w/High dose chemo (BM/SC transplant) |
|
|
Term
Multiple Myeloma symptoms |
|
Definition
20% asymptomatic anemia bone marrow failure renal failure recurrent infections hyperviscosity syndrome Proximal renal tubular acidosis |
|
|
Term
Multiple Myeloma Epidemiology |
|
Definition
average age 65 Males>Females Blacks 2x> Whites 5 year survival-- 25-30% Medial survival-- 30-36 mos |
|
|
Term
Multiple Myeloma Diagnostic Interpretations |
|
Definition
Thrombocytopenia Neutropenia Amyloidosis Lytic lesions Decreased bone density hypercalcemia RBC normal with Rouleau formation Neutrophil/Platelet normal AT FIRST Proteinuria-- Bence Jones Proteins ESR Elevated PBS-- plasma cells rarely visible SPEP-- Paraprotein IgG Production Phosphaturia, glycosuria, uricosuria, aminoaciduria BM biopsy w/5-100% infiltrate plasma cells Deletion of 13q chromosome |
|
|
Term
Multiple Myeloma diagnostic testing |
|
Definition
Bone X-rays IEP, Urine IEP SPEP Bone marrow biopsy PBS ESR |
|
|
Term
Multiple Myeloma Treatments |
|
Definition
-Combo Chemo + VAD -Thalidomide and thalidomide derivatives and experimental agents CC-5013 and PS-341 -Thalidomide, berexomib (PS-341, Velcade), and the experimental agent CC-5013 (Revimid) -Mobilization, hydration, and bisphosphonates for hypercalcemia -Bisphosphonates (eg, pamidronate, 90 mg, or zoledronate, 4 mg IV Q month) to reduce pathological fractures |
|
|
Term
Multiple Myeloma chronic treatment |
|
Definition
-Autologous stem cell transplantation in patients aged <70 -Autologous transplantation useful in relapse if disease still chemotherapy sensitive -Allogeneic transplantation potentially curative, but role limited by unusually high mortality rate |
|
|
Term
|
Definition
5/100,000 people most common pediatric cancer peak 2-6 years Males, Whites, Jews |
|
|
Term
ALL Diagnostic interpretations |
|
Definition
leukemic cells in BM Anemia, thrombocytopenia, neutropenia WBC vary >25% leukemic blast cells hyperuricemia hypomagnesemia hypocalcemia/hypercalcemia low serum immunoglobulins |
|
|
Term
|
Definition
fatigue, pallor, bleeding, infection (respiratory, dental, perirectal, sinus, UTI) Hepatosplenomegaly testes enlargement mimic RA CNS-- vomiting, headache, papilledema, neck stiffness, cranial nerve palsy |
|
|
Term
|
Definition
Radiation therapy TBI-- for BMT Chemo BMT |
|
|
Term
|
Definition
5x more than ALL equally at all ages, slightly more common >50 -elderly 19/100,000 80% of adult leukemia 4.6(M):3.0(W)/100,000 |
|
|
Term
|
Definition
increased fatigue decreased exercise tolerance excess bleeding fevers/recurrent infections headache, vision changes early satiety history of cancer/smoking petechiae, purpura splenomegaly |
|
|
Term
AML diagnostic interpretations |
|
Definition
neutropenia Abn Blood count-- thrombocytopenia leukocytosis, anemia Chromosomal abnormality Auer rods BM w/30% blast cells |
|
|
Term
|
Definition
M3-- retinoic acid (vit a derivative) combo chemo, radiation, BMT |
|
|
Term
CLL diagnostic interpretations |
|
Definition
Chromosomal deletion at 13q14 |
|
|
Term
|
Definition
most common leukemia increase with age median 65, rare under 35 Men>Women White>blacks uncommon in asia |
|
|
Term
|
Definition
new lymphadenopathy fatigue frequent infections bone pain excessive sweating generalized pruritis- after shower easy bruising splenomegaly |
|
|
Term
CLL diagnostic interpretations |
|
Definition
Lymphocytes >10,000 ^ leukemic cells in BM, blood, LN, spleen lymphocytosis anemia, thrombocytopenia CD5/23 (30% have 38) |
|
|
Term
|
Definition
no optimal treatment Chemo for thrombocytopenia/anemia Radiation palliative care for localized tumors Splenectomy for cytopenia |
|
|
Term
CML diagnostic interpretations |
|
Definition
Philadelphia chromosome anemia, thrombocytopenia leukocytosis myeloblasts, promyelocytes, reticulocytes Serum B12 elevated Decreased LAP score BM-- granulocytic/megakaryocytic hyperplasia Left shift on CBC |
|
|
Term
|
Definition
20-30% of leukemias Rare in children, uncommon before 21 Peaks mid 40's Males slightly more common |
|
|
Term
|
Definition
malaise, fatigue, sweating, heat intolerance, easy bruising wt loss, peripheral leg edema splenomegaly-- progressive/painful LUQ discomfort early satiety fever, bone pain, and wt loss from blast crisis |
|
|
Term
|
Definition
Imatinab (Gleevec) 400mg/d PO Radiation-- TBI/spleen Chemo SCT |
|
|
Term
Polycythemia Vera Epidemiolgoy |
|
Definition
2/100,000 people increase with age median 60 yrs old peak 50-70 yrs old men 2x> women (except during reproduction age) |
|
|
Term
Polycythemia Vera Symptoms |
|
Definition
neurologic: vertigo, tinnitus, headache, visual disturbances, transient ischemic attack Venous/arterial thrombosi: Hempatic ven thrombosis/Budd-Chiari Syndrome, MI, stroke, peripheral vascular disease Massive splenomegaly Aquagenic pruritis Easy bruising Erythromelalgia: burning, throbbing, reddness of LE/hands; feet/lower legs flushed and warm; acral parasthesis |
|
|
Term
Polycythemia Vera Diagnostic interpretations |
|
Definition
Elevated red cell mass (>36M, >32W) leukocytosis thrombocytosis LAP increased B12 increased Normal O2 saturation CBC: elevated Hgb, Hct, RBC # MCV decreased Platelet/Leukocyte elevated Plasma EPO LOW Granulocyte alkaline phosphate level elevated tisomy 8 or 9 20q- |
|
|
Term
Polycythemia Vera treatments |
|
Definition
phlebotomy maintain hgb at 14M and 12W Others: hydroxyurea interferon a allogenic BM for young patients |
|
|